Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo, not everyone loses hair on Wegovy. Hair shedding affects a minority of people taking semaglutide for weight loss, and when it does occur, the cause is usually the rapid weight loss itself rather than the medicine. Understanding the difference matters, because the two have very different timelines and outcomes. Wegovy is a prescription-only medicine requiring clinical assessment before it can be supplied.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a disconcerting thing to find. You have been losing weight (which feels like progress) and then the hair starts coming out in larger amounts than usual. Before worrying, it helps to understand what is actually happening biologically.
The hair growth cycle has three phases. During a significant physical stressor (surgery, illness, or rapid weight loss) large numbers of hair follicles can shift simultaneously into the resting phase, called telogen. Around two to four months later, those resting follicles shed their hairs at the same time. The result looks alarming but is almost always temporary. This pattern is well recognised in weight-loss medicine and, as our guide to whether you lose hair on Wegovy explains, is not unique to Wegovy or semaglutide specifically. It has been documented with bariatric surgery, very-low-calorie diets, and other injectable weight-loss treatments.
The NHS medicines page for semaglutide lists hair loss among the possible side effects, meaning it has been reported during clinical use. Reporting in a trial or on a prescribing leaflet does not mean it is inevitable, or even likely, for you personally. It means the regulators and the manufacturer want you to know it can happen.
Semaglutide works by slowing gastric emptying and reducing appetite, which leads to a reduced calorie intake. That reduction, sustained over weeks, is what the hair follicles respond to, not the molecule itself. The distinction is important because it means the same shedding can occur with any intervention that produces meaningful, fast weight loss.
Protein intake is the variable most prescribers focus on. When overall calories fall sharply, people sometimes eat far less protein than their body needs to maintain muscle and support the hair growth cycle. Keeping protein adequacy (roughly spread across meals rather than skipped) is the practical lever you have some control over. Staying well hydrated and not skipping meals entirely are in the same category. None of this replaces advice from your own prescriber or a registered dietitian, who can look at your specific eating pattern and rate of weight loss together.
Iron levels are worth mentioning too. Pre-existing low ferritin (stored iron) can tip into a more obvious deficiency during rapid weight loss, and low ferritin is itself a recognised trigger for telogen effluvium. A GP can check this with a simple blood test if shedding is significant.
For anyone weighing up whether Wegovy is right for them, a broader look at how Wegovy works and what the evidence shows sets the full picture alongside questions like this one.
For most people, the shedding slows and then stops as weight loss stabilises and nutritional intake catches up. Hair typically begins to regrow within a few months of the effluvium phase ending. The regrowth period can feel slower than expected, but the follicles themselves have not been destroyed, the hair is coming back.
You should mention hair loss to your prescriber if it is severe, if it continues beyond six months, if you notice patchy bald areas rather than general thinning, or if it is accompanied by other symptoms such as fatigue or feeling cold. Those patterns can point to a thyroid or iron issue that needs its own investigation, quite apart from Wegovy. Your prescriber can also review your rate of dose escalation if there is concern that very rapid weight loss is a driver.
The MHRA Yellow Card scheme allows patients to report unexpected or troubling side effects (including hair loss) directly to the regulator, and doing so contributes to the ongoing safety monitoring of all licensed medicines. It is always worth knowing the option exists, even if you ultimately resolve it with your own clinical team.
If you are still deciding whether treatment is right for you, whether Wegovy works for everyone is a related question worth reading before starting.
Keeping your pen stored correctly throughout treatment is part of the routine many people build early on, the refrigerator is the right place between uses, and most people slip it into the fridge door next to everyday things so it simply becomes part of the morning. That kind of small habit matters because the medicine working consistently is part of tolerating any early side effects, including the possibility of some hair shedding.
On the broader question of whether weight loss results vary as much as side effects do, the evidence on how much weight people actually lose on Wegovy is worth reading for a realistic expectation of what treatment involves.
The full guide to Wegovy and hair changes covers the topic in more detail, including what other factors can influence the timeline. And if you are curious how semaglutide compares more broadly to other weight-loss medicines, the semaglutide overview sets out the licensed options clearly.
If you are at the stage of thinking about accessing treatment through a regulated service, checking your eligibility with our prescribers is the straightforward next step. Every consultation is reviewed by a GPhC-registered prescriber on the same day (a real clinician, not a triage algorithm) so any questions like this one can be answered in the context of your own situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.